Based on recent data, Jade Biosciences, Inc. (JBIO) shows an Average True Range (ATR) of 1.32 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 925.82K, indicating liquidity. These fundamental metrics provide insight into JBIO's underlying financial health and market activity.
| ATR | 1.32 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 925.82K |
| Avg Vol (10 Days) | 2.02M |
Jade Biosciences, Inc. (JBIO) technical indicators as of June 23, 2026: the SMA 20 is -2.42%, SMA 50 at -3.69%, and SMA 200 at 38.26%. The RSI 14 value is 48.59, suggesting its current momentum. These technical analysis signals help assess JBIO's price trends and potential future movements.
| SMA 20 | -2.42% |
| SMA 50 | -3.69% |
| SMA 200 | 38.26% |
| RSI 14 | 48.59 |
Jade Biosciences, Inc. (JBIO) stock performance overview as of June 23, 2026: The 52-week high is $27.96 (currently -17.79% below), and the 52-week low is $6.67 (currently 121.78% above). Over the past year, JBIO's performance is 71.62%, compared to the S&P 500's 9.62% change.
| 52-Week High | 27.96 |
| 52-Week High Chg | -17.79% |
| 52-Week Low | 6.67 |
| 52-Week Low Chg | +121.78% |
| S&P 500 52-Week Chg | 9.62% |
According to market data, Jade Biosciences, Inc. (JBIO) stock's recent performance metrics show that over the last month, JBIO is -2.74%, with a Year-to-Date (YTD) performance of -1.17%. Over the past year, the stock has seen a 71.62% change. These figures summarize JBIO's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 22.13 | 24 | 27.96 | 27.96 | 27.96 | 27.96 |
| Low | 15.16 | 14.28 | 12.91 | 12.45 | 6.67 | 12.45 |
| Performance | +10.03% | -2.74% | +62.75% | +75.49% | +71.62% | -1.17% |
According to current financial data, JBIO stock's P/E (TTM) ratio is -7.34, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for JBIO, including P/S (N/A), P/B (4.18), and P/FCF (-6.00), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | JBIO | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -7.34 | -1.22 | -5.02 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 462.04 | 5.98 |
| P/B (TTM) | 4.18 | -0.17 | 11.65 | 5.04 |
| P/FCF (TTM) | -6 | -15.22 | -905.79 | 28.54 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep